Prostate Cancer: A Targeted Diagnosis
Fusing Two Tools for an Accurate Diagnosis:
MR/Ultrasound Fusion Biopsy
for a Targeted Diagnosis of Prostate Cancer
Fusion Biopsy compared to a Traditional Biopsy
Combining an MRI pre-biopsy scan with an ultrasound-guided biopsy image can
create a more accurate way to locate tumors.
This innovative technology may result in fewer needle biopsies and better treatment decisions for patients with prostate cancer.
In a traditional core needle biopsy, urologists use a fine needle to collect a number of tissue samples from the prostate gland, which are then examined for cell abnormalities that are a sign of prostate cancer.
Whereas the traditional method lacks precision and uses random prostate sampling, MR/ultrasound fusion biopsy helps urologists to avoid missing hard-to-find, yet often aggressive prostate cancer. It potentially minimizes the overdiagnosis of non-aggressive cancers, while maximizing the likelihood of detecting aggressive tumors.
Biopsies guided by MR/ultrasound fusion enable both physicians and patients to make more informed decisions ranging from prostate cancer diagnosis to treatment options—such as active surveillance or more radical interventions.
Other Tools Used To Diagnose Prostate Cancer
Fox Chase offers a full range of diagnostic tools. In addition, Fox Chase diagnostic physicians are experienced at accurately interpreting the results.
- Digital Rectal Exam (DRE)
- PSA Test
- "Percentage-free" PSA Test
- Prostate Biopsy and Transrectal Ultrasound (TRUS)
- Gleason Grading System After a Biopsy
The Core Needle Biopsy for Prostate Cancer Diagnosis
A core needle biopsy is the main method used to diagnose prostate cancer. It takes just a few minutes to perform and may produce some temporary discomfort.
In this procedure, a sample of tissue is removed and then examined under a microscope. The doctor inserts several narrow needles (usually through the wall of the rectum) into the prostate gland, using transrectal ultrasound (TRUS) to guide the needles to the prostate. Each needle then removes a cylinder of tissue, or core, usually about 1/2-inch long and 1/16-inch across. The tissue samples are sent to the laboratory where a pathologist checks the tissue under a microscope to see if cancer is present. If cancer is present, the pathologist will also assign it a Gleason grade.
Topics in This Section
Making the Best Decisions: A Novel Study for Men with Newly-Diagnosed Prostate Cancer
Aug 6, 2014
Investigators at Fox Chase Cancer Center have a new study available for men with a recent diagnosis of localized prostate cancer (meaning the cancer is contained in the prostate and has not spread). It's focused on helping men to make the best decision about their prostate cancer treatment.
Read more at
Cancer Conversations »
Cancer diagnosis information for patients from the College of American Pathologists